Publications dans lesquelles il/elle collabore avec Rosa Laura Vicente Vicente (23)

2024

  1. Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis

    Frontiers in Pharmacology, Vol. 15

  2. Nefrotoxicidad asociada a la combinación de cisplatino e inhibidores del punto de control inmunitario. Estudio histopatológico

    Farmajournal, Vol. 9, Núm. 1, pp. 7-17

  3. Urinary GM2AP coincides with renal cortical damage and grades cisplatin nephrotoxicity severity in rats

    Toxicology, Vol. 508

2023

  1. Caracterización funcional del daño renal asociado a la inmunoterapia oncológica

    Farmajournal, Vol. 8, Núm. 1, pp. 7-19

  2. New Challenges in the Diagnosis of Kidney Damage Due to Immune Checkpoint Inhibitors Therapy: An Observational Clinical Study

    Diagnostics, Vol. 13, Núm. 15

  3. “Adivina el envenenamiento”: un juego para aprender toxicología a través de Instagram

    Farmajournal, Vol. 8, Núm. 2, pp. 39-40

2022

  1. Diagnosis of Cardiac Surgery-Associated Acute Kidney Injury: State of the Art and Perspectives

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  2. Early Diagnosis of Kidney Damage Associated with Tobacco Use: Preventive Application

    Journal of Personalized Medicine, Vol. 12, Núm. 7

  3. Evaluación histológica del daño renal producido por los inhibidores del punto de control inmunitario

    Farmajournal, Vol. 7, Núm. 2, pp. 53-65

2021

  1. Albuminuria pre-emptively identifies cardiac patients at risk of contrast-induced nephropathy

    Journal of Clinical Medicine, Vol. 10, Núm. 21

  2. Are antioxidants useful in preventing the progression of chronic kidney disease?

    Antioxidants, Vol. 10, Núm. 11

  3. Detección del riesgo de lesión renal en fumadores

    Farmajournal, Vol. 6, Núm. 2, pp. 49-62

  4. Regression modeling of the antioxidant-to-nephroprotective relation shows the pivotal role of oxidative stress in cisplatin nephrotoxicity

    Antioxidants, Vol. 10, Núm. 9

2020

  1. A meta-analysis of preclinical studies using antioxidants for the prevention of cisplatin nephrotoxicity: implications for clinical application

    Critical Reviews in Toxicology, Vol. 50, Núm. 9, pp. 780-800

  2. Designing new diagnostic systems for the early detection of tobacco-associated chronic renal damage in patients of a primary care centre in Salamanca, Spain: An observational, prospective study protocol

    BMJ Open, Vol. 10, Núm. 3

  3. Predisposición adquirida al daño renal asociada al consumo de tabaco

    Farmajournal, Vol. 5, Núm. 1, pp. 7-15

  4. Systematic review and meta-analysis of the efficacy of clinically tested protectants of cisplatin nephrotoxicity

    European Journal of Clinical Pharmacology, Vol. 76, Núm. 1, pp. 23-33

  5. Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations

    Biomedicine and Pharmacotherapy, Vol. 121

2019

  1. Quercetin, a promising clinical candidate for the prevention of contrast-induced nephropathy

    International Journal of Molecular Sciences, Vol. 20, Núm. 19

2017

  1. A systematic meta-analysis on the efficacy of pre-clinically tested nephroprotectants at preventing aminoglycoside nephrotoxicity

    Toxicology, Vol. 377, pp. 14-24